We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Springer Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
Price data last checked 107 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia provides a comprehensive understanding of the recent molecular genetics of Chronic Myelogenous Leukemia (CML) and a characterization of the molecular targets for drug development. Included are therapeutic implications, diagnosis, and prognosis for understanding and facilitating daily practice in the management of patients with CML. Understanding of the pathogenesis and therapy of hematological malignancies such as CML has grown significantly in recent years. This development owe much to the progress in molecular biology and now makes a major contribution to diagnosis and to treatment that pharmacologically targets the molecular events of CML. Molecular targeting therapy with newly developed agents such as small molecules and antibodies for hematological malignancies are being discovered after years of research. Some of these, including tyrosine kinase inhibitors such as imatinib, nilotinib, and dasatinib, lead to increased survival rates and improved therapies. With the opinion leaders of basic and clinical research in the field as authors, this book reviews recent advances in the biology of CML.
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 4431562559
- Domain
- Amazon UK
- Release Date
- 23 August 2016
- Listed Since
- 14 May 2016
Barcode
No barcode data available
Similar Products You Might Like
95% match
CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)
£113.67
09 Jan 2026
95% match
Pathogenesis and Treatment of Leukemia
£145.03
12 Jan 2026
95% match
Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)
Springer
£110.29
12 Dec 2025
95% match
Acute Myelogenous Leukemia (Contemporary Hematology)
Humana
£164.16
09 Jan 2026
94% match
Springer Hematologic Cancers: Molecular Pathobiology to Therapy
Springer
£113.48
20 Apr 2026
94% match
Chemotherapy for Leukemia: Novel Drugs and Treatment
Springer
£105.45
09 Mar 2026
94% match
Springer Hematologic Cancers: Molecular Pathobiology Book
Springer
£112.91
03 Mar 2026
94% match
Acute Myeloid Leukemia (Hematologic Malignancies)
£92.25
08 Jan 2026
94% match
Molecular Aspects of Hematologic Malignancies: Diagnostic Tools and Clinical Applications (Principles and Practice)
Springer
£114.53
12 Dec 2025
94% match
Chronic Myeloid Leukemia: A Handbook for Hematologists and Oncologists
CRC Press
£51.99
07 Mar 2026
93% match
Myeloproliferative Disorders (Hematologic Malignancies)
Springer
£94.99
21 Feb 2026
93% match
Acute Leukemias (Hematologic Malignancies)
Springer
£103.69
12 Jan 2026
93% match
The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America (Volume 31-4) (The Clinics: Internal Medicine, Volume 31-4)
Elsevier
£68.41
08 Mar 2026
93% match
Hematologic Malignancies: An Overview - Hematology Research
Out of Stock
17 Apr 2026
93% match
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
Springer
£122.70
07 Mar 2026
93% match
Advance in the Treatment of Pediatric Leukemia
£59.98
08 Mar 2026
93% match
Springer Multiple Myeloma and Plasma Cell Neoplasms Book
Springer
£109.79
22 Feb 2026
93% match
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
Springer
£79.70
22 Feb 2026
93% match
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
£116.62
13 Jan 2026
93% match
Chronic Lymphocytic Leukemia: Pathobiology, B Cell Receptors, Novel Mutations, Clonal Evolution (Molecular and Translational Medicine)
Humana
£69.42
24 Feb 2026
93% match
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
Springer
£107.43
01 Mar 2026
93% match
Myeloproliferative Disorders (Hematologic Malignancies)
Springer
£84.58
01 Feb 2026
93% match
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
Springer
£99.53
25 Feb 2026
93% match
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
CRC Press
£147.25
13 Apr 2026